milrinone has been researched along with Drug Withdrawal Symptoms in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The safety and efficacy of long-term oral milrinone therapy were evaluated over a 2 1/2 year period in 100 patients who had severe congestive heart failure despite conventional therapy." | 7.67 | Survival of patients with severe congestive heart failure treated with oral milrinone. ( Baim, DS; Braunwald, E; Colucci, WS; Gauthier, DF; Grossman, W; Lanoue, A; Monrad, ES; Ransil, BJ; Smith, HS; Wright, RF, 1986) |
| "The safety and efficacy of long-term oral milrinone therapy were evaluated over a 2 1/2 year period in 100 patients who had severe congestive heart failure despite conventional therapy." | 3.67 | Survival of patients with severe congestive heart failure treated with oral milrinone. ( Baim, DS; Braunwald, E; Colucci, WS; Gauthier, DF; Grossman, W; Lanoue, A; Monrad, ES; Ransil, BJ; Smith, HS; Wright, RF, 1986) |
| " In the present study, a digoxin dose-response curve was conducted to observe the effects on naloxone-precipitated withdrawal and locomotor activity in mice." | 1.38 | A comparison of the effects of digoxin, ouabain and milrinone on naloxone-precipitated withdrawal syndrome in mice. ( Bai, YL; Chen, YY; Chu, QJ; Li, J; Li, WJ; Zhang, Q, 2012) |
| "Seven patients with severe chronic congestive heart failure were treated with a new cardiotonic agent, WIN 47203 (an analog of amrinone), for an average of 7." | 1.27 | Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease. ( Chadwick, B; Forman, R; Le Jemtel, TH; Maskin, CS; Sinoway, LS; Sonnenblick, EH, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, YL | 1 |
| Chu, QJ | 1 |
| Li, J | 1 |
| Chen, YY | 1 |
| Li, WJ | 1 |
| Zhang, Q | 1 |
| Sinoway, LS | 1 |
| Maskin, CS | 1 |
| Chadwick, B | 1 |
| Forman, R | 1 |
| Sonnenblick, EH | 1 |
| Le Jemtel, TH | 1 |
| Baim, DS | 1 |
| Colucci, WS | 1 |
| Monrad, ES | 1 |
| Smith, HS | 1 |
| Wright, RF | 1 |
| Lanoue, A | 1 |
| Gauthier, DF | 1 |
| Ransil, BJ | 1 |
| Grossman, W | 1 |
| Braunwald, E | 1 |
3 other studies available for milrinone and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
A comparison of the effects of digoxin, ouabain and milrinone on naloxone-precipitated withdrawal syndrome in mice.
Topics: Animals; Cardiotonic Agents; Digoxin; Female; Male; Mice; Milrinone; Morphine; Motor Activity; Nalox | 2012 |
Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease.
Topics: Cardiac Output; Cardiotonic Agents; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; | 1983 |
Survival of patients with severe congestive heart failure treated with oral milrinone.
Topics: Administration, Oral; Adult; Aged; Cardiotonic Agents; Electrocardiography; Female; Heart Failure; H | 1986 |